Review Article
Volume 8 Issue 6 - 2020
Can Punica granatum be a Miracle in Ameliorating Obesity? - A Short Review
Khoshnur Jannat1, Nusratun Nahar2, Tohmina Afroze Bondhon1, Anamul Hasan1 and Mohammed Rahmatullah1*
1Department of Biotechnology and Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka, Bangladesh
2Department of Pharmacy, Southeast University, Banani, Dhaka, Bangladesh
*Corresponding Author: Mohammed Rahmatullah, Professor and Dean, Faculty of Life Sciences, Department of Biotechnology and Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka, Bangladesh.
Received: March 03, 2020; Published: May 14, 2020




Abstract

Metabolic syndrome (MetS) is a combination of several biological and physiological abnormalities including insulin resistance, hypertension, obesity, adiposity, atherogenic dyslipidemia, endothelial dysfunction, which are interrelated. A combination of a number of these factors, all present in a single individual, not only lowers the life expectancy but also lowers the quality of life. MetS is becoming a grave concern and major scientific efforts are underway to treat MetS with plant-based extracts or phytochemicals. This review attempts to summarize some aspects of the current state of knowledge obtained with Punica granatum or pomegranate fruits and other parts of the plant in ameliorating obesity - a key component of MetS.

Keywords: Metabolic Syndrome; Obesity; Punica granatum; Pomegranate; Body Mass Index

References

  1. Huang PL. “A comprehensive definition of metabolic syndrome”. Disease Model and Mechanism 5-6 (2009): 231-237.
  2. Wang Q., et al. “Metabolic syndrome knowledge among adults with cardiometabolic risk factors: a cross sectional study”. International Journal of Environmental Research and Public Health 1 (2019): E159.
  3. Kaur J. “A comprehensive review on metabolic syndrome”. Cardiology Research and Practice 2014 (2014): 943162.
  4. Grundy SM., et al. “Definition of metabolic syndrome”. Circulation3 (2004): 433-438.
  5. Salamt N., et al. “The effect of exercise on vascular markers and C-reactive protein among obese children and adolescents: An evidence based review”. Bosnian Journal of Basic Medical Sciences (2019).
  6. O’Neill S and O’Driscoll L. “Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies”. Obesity Reviews 1(2015): 1-12.
  7. Saklayen MG. “The global epidemic of metabolic syndrome”. Current Hypertension Reports 2 (2018): 12.
  8. Zhang Z., et al. “Impact of fecal microbiota transplantation on obesity and metabolic syndrome- a systematic review”. Nutrients 10 (2019): E2219.
  9. Hruby A and Hu BF. “The epidemiology of obesity: a big picture”. Pharmacoeconomics7 (2015): 673-689.
  10. Biswas T., et al. “Increasing prevalence of overweight and obesity in Bangladeshi women of reproductive age: finding from 2004 to 2014”. PLOS ONE 7 (2017): e0181080.
  11. Tanwi ST., et al. “Socioeconomic correlates of overweight and obesity among ever-married urban women in Bangladesh”. BMC Public Health 19 (2019): 842.
  12. Swinburn BA., et al. “The global obesity pandemic: shaped by global drivers and local environments”. Lancet 378 (2011): 804-814.
  13. Zamsad M., et al. “Prevalence of overweight, obesity and abdominal obesity in Bangladesh university students: A cross-sectional study”. Diabetes and Metabolic Syndrome 1 (2019): 480-483.
  14. Sullivan NA and Lachman EM. “Behavior change with fitness technology in sedentary adults: a review of the evidence for increasing physical activity”. Frontiers Public Health 4 (2016): 289.
  15. Burgess, E., et al. “Determinants of adherence to lifestyle intervention in adults with obesity: a systematic review”. Clinical Obesity3 (2017): 123-135.
  16. Tek C. “Naltrexone HCl/bupropion HCl for chronic weight management in obese adults: patient selection and perspective”. Patient Preference and Adherence 10 (2016): 751-759.
  17. Arun N and Singh DP. “Punica granatum: a review on pharmacological and therapeutic properties”. International Journal of Pharmaceutical Science and Research 3 (2012): 1240-1245.
  18. Rahmani AH., et al. “Active constituents of pomegranates (Punica granatum) as potential candidates in the management of health through modulation of biological activities”. Pharmacognosy Journal 5 (2017): 689-695.
  19. Gheflati A., et al. “Does pomegranate consumption affect weight and body composition? A systematic review and meta-analysis of randomized controlled clinical trials”. Phytotherapy Research 33 (2019) 1277-1288.
  20. Apovian CM. 2016. “Obesity: definition, comorbidities, causes, and burden”. The American Journal of Managed Care7 (2016): S176-S185.
  21. Pi-Sunyer XF. “Obesity: criteria and classification”. The Proceeding of Nutrition Society4 (2000): 505-509.
  22. James TPW., et al. “Overweight and obesity (high body mass index)- chapter 8”. Comparative Qualification of Health Risks 1 (20004): 0497-0596.
  23. Freitas Jr LM and Almeida Jr EB. “Medicinal plants for the treatment of obesity: ethnopharmacological approach and chemical and biological studies”. American Journal of Translational Research 5 (2017): 2050-2064.
  24. Gamboa-Gómez IC., et al. “Plants with potential use on obesity and its complications”. EXCLI Journal 14 (2015): 809-831.
  25. Mukherjee, A., et al. “Phytochemicals in obesity control”. International Journal of Current Microbiology and Applied Sciences 4 (2015): 558-567.
  26. Karri S., et al. “Natural anti-obesity agents and their therapeutic role in management of obesity: A future trend perspective”. Biomedicine and Pharmacotherapy 110 (2019): 224-238.
  27. Medjakovic S and Jungbauer A. “Pomegranate: a fruit that ameliorates metabolic syndrome”. Food and Function 1 (2013): 19-39.
  28. Al-Muammar MN and Khan F. “Obesity: The preventive role of pomegranate (Punica granatum)”. Nutrition 6 (2012): 595-604.
  29. Rummun, N., et al. “Bioactivity of nonedible parts of Punica granatum: A potential source of functional ingredients”. International Journal of Food Sciences 2013 (2013).
  30. Lei F., et al. “Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice”. International Journal of Obesity 6 (2007): 1023-1029.
  31. Adnyana IK., et al. “Anti-obesity effect of the pomegranate leaves ethanol extract (Punica granatum ) in high-fat diet induced mice”. International Journal of Pharmacy and Pharmaceutical Sciences 6.4 (2014): 626-631.
  32. Konstantinidi M and Koutelidakis AE. “Functional food and bioactive compounds: A review of its possible role on weight management and obesity’s metabolic consequences”. Medicines3 (2019): E94.
  33. Bounihi A., et al. “Fruit vinegars attenuate cardiac injury via anti-inflammatory and anti-adiposity actions in high-fat diet-induced obese rats”. Pharmaceutical Biology1 (2017): 43-52.
  34. Ahmed MM., et al. “Anti-obesity effects of Taif and Egyptian pomegranates: molecular study”. Bioscience, Biotechnology and Biochemistry4 (2015): 598-609.
  35. Foretz M., et al. “Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes”. Proceeding of the National Acadamy of Sciences of the United States of America22 (1999): 12737-12742.
  36. Ok E., et al. “Pomegranate vinegar attenuates adiposity in obese rats through coordinated control of AMPK signaling in the liver and adipose tissue”. Lipids Health and Disease 12 (2013): 163.
  37. Khabeer TS., et al. “Dietary fatty acids from pomegranate seeds (Punica granatum) inhibit adipogenesis and impact the expression of the obesity-associated mRNA transcripts in human adipose-derived mesenchymal stem cells”. Journal of Food Biochemistry3 (2019):e12739.
  38. Abidov M., et al. “The effects of xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat”. Diabetes Obesity and Metabolism1 (2010): 72-81.
  39. Motawi TK., et al. “Peroxisome proliferator-activated receptor gamma in obesity and colorectal cancer: the role of epigenetics”. Scientific Reports 7 (2017): 10714.
  40. Darlington GJ., et al. “The role of C/EBP genes in adipocyte differentiation”. The Journal of Biological Chemistry46 (1998): 30057-30060.
  41. Lai CS., et al. “Xanthigen suppresses preadipocyte differentiation and adipogenesis through down-regulation of PPARγ and C/EBPs and modulation of PPARg and CEBPs and modulation of SIRT-1, AMPK, and FoxO pathways”. Journal of Agricultural and Food Chemistry4 (2012): 1094-1101.
  42. Chatterjee S., et al. “Therapeutic fruit peels: Their role in preventing lifestyle disorders”. Recent Research in Science and Technology1 (2014): 283-286.
  43. Parmar HS and Kar A. “Medicinal values of fruit peels from Citrus sinensis, Punica granatum, and Musa paradisiac with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones”. Journal of Medicinal Foods2 (2008): 376-381.
  44. Sorrenti V., et al. “Beneficial effect of pomegranate peel extract and probiotics on pre-adipocyte differentiation”. Frontiers in Microbiology 10 (2019): 660.
  45. Kang B., et al. “Punicalgin, a pomegranate derived ellagitannin suppress obesity and obesity-induced inflammatory responses via the Nrf2/Keap1 signaling pathway”. Molecular Nutrition and Food Research22 (2019): e1900574.
  46. Les F., et al. “Pomegranate polyphenols and urolithin A inhibit a glucosidase, dipeptidyl peptidase-4, lipase, triglyceride accumulation, and adipogenesis related genes in 3T3-L1 adipocyte like cells”. Journal of Ethnopharmacology 220 (2018): 67-74.
  47. Heber D., et al. “Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size”. Journal of Agricultural and Food Chemistry24 (2007): 10050-10054.
  48. Angel A and Roncari DAK. “Medical complications of obesity”. Canadian Medical Association Journal 119 (1978): 1408-1411.
  49. Yang J., et al. “Cholesterol-lowering effects of dietary pomegranate extract and inulin in mice fed an obesogenic diet”. The Journal of Nutritional Biochemistry 52 (2018): 62-69.
  50. Amri Z., et al. “Effect of pomegranate extracts on brain antioxidant markers and cholinesterase activity in high fat-high fructose diet induced obesity in rat model”. BMC Complementary and Alternative Medicine1 (2017): 339.
  51. Noori M., et al. “Pomegranate juice prevents development of non-alcoholic fatty liver disease in rats by attenuating oxidative stress and inflammation”. Journal of the Science of Food Agriculture8 (2017): 2327-2332.
  52. Al-Shaaibi S.N., et al. “Ameliorative Effects of Pomegranate Peel Extract against Dietary-Induced Nonalcoholic Fatty Liver in Rats”. Preventive Nutrition and Food Science1 (2016): 14-23.
  53. Harzallah A., et al. “Comparison of potential preventive effects of pomegranate flower, peel and seed oil on insulin resistance and inflammation in high-fat and high-sucrose diet-induced obesity mice model”. Archives of Physiology and Biochemistry2 (2016): 75-87.
  54. Vini R., et al. “Evidence of pomegranate methanolic extract in antagonizing the endogenous SERM, 27-hydroxycholesterol”. IUBMB Life2 (2016): 116-121.
  55. Nelson ER. “Detection of endogenous selective receptor modulator such as 27-hydrocholesterol”. Methods in Molecular Biology 1366 (2016): 431-443.
  56. Cao K., et al. “Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation”. Science Reports 5 (2015): 14014.
  57. Yoshimura Y., et al. “Ellagic acid improves hepatic steatosis and serum lipid composition through reduction of serum resistin levels and transcriptional activation of hepatic ppara in obese, diabetic KK-A(y) mice”. Biochemical and Biophysical Research Communications3 (2013): 486-491.
  58. Yoshiaki K., et al. “Diabetic mouse models”. Open Journal of Animal Sciences 3 (2013): 334-342.
Citation: Mohammed Rahmatullah., et al. “Can Punica granatum be a Miracle in Ameliorating Obesity? - A Short Review”. EC Pharmacology and Toxicology 8.6 (2020): 52-60.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and can be viewed in the current issue pages.

Submission Deadline for July Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the June issue of respective journals. Submissions are accepted on/before June 11, 2020.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk